The Global Rapid Oral Fluid Screening Device Market is expected to grow at a CAGR of roughly 12.60% between 2022 and 2027.
Rapid oral fluid screening devices can perform a variety of screening tasks. The medical equipment known as rapid oral fluid screening devices is used to identify drugs and move them through clinical trials until a candidate product is chosen. One of the key elements driving the market's expansion is the rise in the use of illegal drugs, alcohol, and narcotics. Another factor influencing market expansion is an increase in the need for drug and alcohol testing. Other significant factors that will contribute to the development of lucrative market growth opportunities include the implementation of strict rules requiring mandatory drug and alcohol testing, the expansion of physician, independent healthcare provider, and hospital-based laboratory applications, and the rise in medical tourism. The necessity for drug and alcohol testing grows as there are more and more people who are dependent on them, resulting in ongoing business prospects for producers. Additionally, the development of quick oral fluid screening equipment by physician, independent, and hospital-based laboratories to execute the diagnostic processes, as well as the strict rules set in place for mandated drug and alcohol testing, are helping the industry expand.
16.12.2021: Roche receives CE mark for the use of saliva samples with cobas® SARS-CoV-2 Qualitative test on cobas® 6800/8800 Systems--
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its cobas® SARS-CoV-2 Qualitative test has received CE mark for the use of saliva samples in the detection of SARS-CoV-2 on the widely available, high-throughput cobas® 6800/8800 Systems. This non-invasive test is for any individual, including those suspected of COVID-19 and those without symptoms. Saliva sample collection represents a convenient testing approach for patients, who can easily self-collect their own samples.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
North America is predicted to lead the entire market throughout the projection period. The market is expanding as a result of things like the high rate of drug usage and the government's stricter rules and requirements for drug and alcohol tests. According to the National Institute on Drug Abuse, 21 to 29 % prescribed opioids for chronic pain abuse them, and 46,802 Americans died from opioid overdoses in 2018, including prescription opioids, heroin, and illicitly made fentanyl, a strong synthetic opioid. According to the Centers for Disease Control and Prevention, the overall annual cost of prescription opioid misuse in the United States, including medical expenses, productivity losses, addiction treatment expenditures, and criminal fines and penalties, is estimated to be USD 78.5 billion.
The Rapid Oral Fluid Screening Device Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Rapid Oral Fluid Screening Device Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 12.60% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | OraSure Technologies, Quest Diagnostics, Abbott Laboratories, Premier Biotech, Neogen Corporation, Salimetrics, Draeger, Securetec Detektions-Systeme, Oranoxis Inc, Lin-Zhi International, Oasis Diagnostics, Cell Projects, Prometheusbio, Guangzhou Wondfo Biotech Co., Ltd, SCREEN ITALIA SRL, MEDACX Ltd, AccuBioTech Co. Ltd, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings., Omega Laboratories, Inc., F. Hoffmann-La Roche Ltd, Shimadzu Corporation, UCP Biosciences, Inc. |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 162 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Rapid Oral Fluid Screening Device Market?
The Rapid Oral Fluid Screening Device Market is growing at a CAGR of 12.60% over the next 5 years.
Who are the key players in Rapid Oral Fluid Screening Device Market?
OraSure Technologies, Quest Diagnostics, Abbott Laboratories, Premier Biotech, Neogen Corporation, Salimetrics, Draeger, Securetec Detektions-Systeme, Oranoxis Inc, Lin-Zhi International, Oasis Diagnostics, Cell Projects, Prometheusbio, Guangzhou Wondfo Biotech Co., Ltd, SCREEN ITALIA SRL, MEDACX Ltd, AccuBioTech Co. Ltd, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings., Omega Laboratories, Inc., F. Hoffmann-La Roche Ltd, Shimadzu Corporation, UCP Biosciences, Inc.
What are the significant types of Rapid Oral Fluid Screening Device Market?
Cassettes, Swabs, Strips
What are the major end-use applications of Rapid Oral Fluid Screening Device Market?
Workplace Testing, Criminal Justice Testing, Rehabilitation Therapy, Others
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.